Our data indicate that Bcl-2 and c-IAP2 represent the core of the SCAP in TMZ-induced senescence and, therefore, point to the need for in vivo studies, targeting these factors to improve TMZ-based glioblastoma therapy. This evidence concerns the gene BCL2 and glioblastoma.